Analysts: Akzo Nobel NV (AKZOY.PK)
20.85USD
24 May 2013
$-0.01 (-0.05%)
$20.86
$20.85
$20.87
$20.80
4,457
50,370
$23.58
$14.45
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Underperform | -- | December | 25 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 0 | 0 | 0 | 0 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 4.00 | 4.00 | 4.00 | 4.00 |
Consensus Estimates Analysis
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-13 | 1 | 19,638.70 | 19,638.70 | 19,638.70 | 23,035.70 |
| Year Ending Dec-14 | 1 | 20,482.00 | 20,482.00 | 20,482.00 | -- |
| Earnings (per share) | |||||
| Year Ending Dec-13 | 1 | 1.00 | 1.00 | 1.00 | 1.14 |
| Year Ending Dec-14 | 1 | 1.32 | 1.32 | 1.32 | -- |
| LT Growth Rate (%) | 1 | 11.10 | 11.10 | 11.10 | 11.10 |
Historical Surprises
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-08 | 4,618.01 | 4,534.40 | 83.61 | 1.81 |
| Quarter Ending Jun-08 | 6,019.15 | 6,090.46 | 71.31 | 1.18 |
| Quarter Ending Mar-08 | 5,920.90 | 5,453.41 | 467.48 | 7.90 |
| Quarter Ending Sep-07 | 3,694.41 | 3,677.82 | 16.59 | 0.45 |
| Quarter Ending Jun-07 | 3,777.96 | 3,710.00 | 67.96 | 1.80 |
Consensus Estimates Trend
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-13 | 19,638.70 | 19,638.70 | 19,661.30 | 20,625.30 | 23,035.70 |
| Year Ending Dec-14 | 20,482.00 | 20,482.00 | 20,505.60 | 21,460.90 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Year Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-14 | 0 | 0 | 0 | 1 |
| Earnings | ||||
Earnings vs. 
Estimates- BRIEF-AkzoNobel shares down after Q1 meets forecasts
- AkzoNobel Q1 in line, sees no improvement in business environment
- DNA discoverer Crick's Nobel, letter fetch millions at auction
- UPDATE 1-TNT Express names former AkzoNobel executive as new CEO
- UPDATE 1-AkzoNobel to speed up cost cutting, sets new targets
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
